Hemoglobin-degrading plasmepsin II is active as a monomer

Area of Science:

• Biochemistry
• Parasitology
• Molecular Biology

Background:

• Plasmepsins are aspartic proteases essential for hemoglobin degradation within Plasmodium parasites.
• Plasmepsin II (PM II) is a key enzyme in this process, and its crystal structures suggest it forms homodimers.
• The functional oligomeric state of PM II in solution remains uncertain, impacting our understanding of its mechanism.

Purpose of the Study:

• To determine the oligomeric state of Plasmepsin II (PM II) in solution.
• To investigate the functional significance of the monomeric versus dimeric form of PM II.
• To identify key structural features responsible for PM II's catalytic activity in hemoglobin degradation.

Main Methods:

• Gel filtration chromatography to assess molecular size and oligomeric state.
• Site-directed mutagenesis to probe the role of specific protein regions.
• Analytical ultracentrifugation for detailed analysis of solution behavior.

Main Results:

• Plasmepsin II predominantly exists as a monomer in solution, contrary to expectations from crystal structures.
• The monomeric form of PM II is catalytically active in degrading hemoglobin.
• A specific hydrophobic loop on the PM II monomer surface, normally buried in dimers, is critical for its function.

Conclusions:

• The functional form of Plasmepsin II in solution is the monomer, not the dimer.
• Understanding the monomeric structure and function is key to inhibiting Plasmodium parasite activity.
• Targeting the exposed hydrophobic loop could be a strategy for developing new antimalarial drugs.